Mergers & Acquisitions


Current filters:


Popular Filters

676 to 700 of 921 results

Validus Pharma gets rights to six Novartis drugs in USA


USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired…

GenericsMergers & AcquisitionsNovartisValidus Pharma

Geron signs tentative deal with BioTime on stem cell assets


A year after announcing its decision to exit stem cell therapy, the USA's Geron Corp (Nasdaq: GERN) has…

BiotechnologyBioTimeFinancialGeron CorpMergers & Acquisitions

Allergan to acquire SkinMedica business for $350 million


US drug firm Allergan (NYSE: AGN), best known as the maker Botox (onabotulinumtoxinA) anti-wrinkle injections,…

AllerganDermatologicalsMergers & AcquisitionsPharmaceuticalSkinMedica

Reckitt Benckiser trumps Bayer's bid for control of Schiff Nutritional


In a move that looks set to thwart Germany-based Bayer's (BAYN: DE) plans to acquire the US nutritional…

BayerMergers & AcquisitionsPharmaceuticalReckitt BenckiserSchiff Nutrition International

AFK Sistema cleared to take over Russian drugmaker Veropharm


Shares in Russian companies 36.6 and Veropharm surged in Monday afternoon trading on the Moscow Stock…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalRegulationVeropharm

Myrexis board approves liquidation and dissolution plan


US cancer and autoimmune diseases drug developer Myrexis (Nasdaq: MYRX) said on Friday that its board…

FinancialMergers & AcquisitionsMyrexisPharmaceutical

Sun Pharma to acquire DUSA Pharmaceuticals for $230 million


India's Sun Pharmaceutical Industries (SUN.BO) has entered into a definitive agreement to acquire US…

DermatologicalsDUSA PharmaceuticalsLevulanMergers & AcquisitionsPharmaceuticalSun Pharmaceutical Industries

Immune Pharmaceuticals to acquire EpiCept under stock merger accord


Privately-held Israeli company Immune Pharmaceuticals and US drug developer EpiCept Corp (Nasdaq: EPCT)…

EpiCeptImmune PharmaceuticalsInflammatory diseasesMergers & AcquisitionsOncologyPharmaceutical

Otsuka Pharma sets up joint venture in Turkey


Otsuka Pharmaceutical (TYO: 4768), a mid-size Japanese drugmaker, and Abdi ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������°brahim…

Abdi IbrahimEuropeMarkets & MarketingMergers & AcquisitionsOtsukaPharmaceutical

Another acquisition for Takeda, Envoy Therapeutics for up to $140 million


Takeda Pharmaceutical (TYO: 4502), Japan's largest drugmaker, has clearly not quenched its thirst for…

Envoy TherapeuticsMergers & AcquisitionsNeurologicalPharmaceuticalTakeda Pharmaceuticals

Exonhit to acquire InGen BioSciences for 18 million euros


French drug discovery and development firm Exonhit Therapeutics (ALEHT:FP) has entered into an agreement…

DiaxonhitExonhit TherapeuticsInGen BioSciencesMergers & AcquisitionsPharmaceutical

AFK Sistema may acquire Russian drugmaker Veropharm


AFK Sistema, the financial conglomerate owned by the Russian billionaire Vladimir Yevtushenko, is considering…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalVeropharm

Charles River Labs to buy majority stake in China's Vital River


USA-based Charles River Laboratories International (NYSE:CRL) has entered into an agreement to acquire…

Asia-PacificCharles River LaboratoriesMergers & AcquisitionsPharmaceuticalVital River

Allergan 4th-qtr revenues up 6%; earnings exceed expectations


US health care firm Allergan (NYSE: AGN) revealed yesterday that revenues for its fiscal fourth-quarter…

AllerganFinancialMergers & AcquisitionsPharmaceutical

Revised terms for ViiV Healthcare and Shionogi HIV partnership


UK pharma giant GlaxoSmithKline (LSE: GSK) says that Healthcare, its HIV/AIDS joint venture with Pfizer,…

Anti-viralsdolutegravirGlaxoSmithKlineMergers & AcquisitionsPfizerPharmaceuticalShionogiViiV Healthcare

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics


Spain's largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech…

AB-BioticsAlmirallBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Pfizer to buy NextWave Pharma for as much as $680 million


Global drugs behemoth Pfizer (NYSE: PFE) revealed yesterday that it is prepared to pay up to $680 million…

GenericsMergers & AcquisitionsNextWave PharmaceuticalsPfizerPharmaceuticalQuillivant

BioCryst and Presidio to merge, creating new competitor in HCV arena


USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately…

Anti-viralsBioCryst PharmaceuticalsMergers & AcquisitionsPharmaceuticalPresidio Pharmaceuticals

676 to 700 of 921 results

Back to top